Envestnet Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.6K | Buy |
47,466
+25,083
| +112% | +$43.1K | ﹤0.01% | 4359 |
|
|
2025
Q1 | $74.5K | Sell |
22,383
-5,548
| -20% | -$18.5K | ﹤0.01% | 4268 |
|
|
2024
Q4 | $207K | Sell |
27,931
-1,446
| -5% | -$10.7K | ﹤0.01% | 4083 |
|
|
2024
Q3 | $276K | Buy |
29,377
+3,584
| +14% | +$33.7K | ﹤0.01% | 3872 |
|
|
2024
Q2 | $207K | Sell |
25,793
-5,575
| -18% | -$44.7K | ﹤0.01% | 3917 |
|
|
2024
Q1 | $465K | Buy |
31,368
+6,957
| +28% | +$103K | ﹤0.01% | 3487 |
|
|
2023
Q4 | $198K | Sell |
24,411
-367
| -1% | -$2.98K | ﹤0.01% | 3829 |
|
|
2023
Q3 | $113K | Buy |
24,778
+5,796
| +31% | +$26.4K | ﹤0.01% | 3853 |
|
|
2023
Q2 | $134K | Sell |
18,982
-3,773
| -17% | -$26.6K | ﹤0.01% | 3795 |
|
|
2023
Q1 | $139K | Buy |
+22,755
| New | +$139K | ﹤0.01% | 3737 |
|
|
2022
Q2 | – | Sell |
-14,017
| Closed | -$233K | – | 3984 |
|
|
2022
Q1 | $233K | Buy |
14,017
+2,099
| +18% | +$34.9K | ﹤0.01% | 3598 |
|
|
2021
Q4 | $228K | Buy |
11,918
+64
| +0.5% | +$1.22K | ﹤0.01% | 3586 |
|
|
2021
Q3 | $292K | Sell |
11,854
-890
| -7% | -$21.9K | ﹤0.01% | 3307 |
|
|
2021
Q2 | $332K | Sell |
12,744
-656
| -5% | -$17.1K | ﹤0.01% | 3230 |
|
|
2021
Q1 | $424K | Buy |
13,400
+8
| +0.1% | +$253 | ﹤0.01% | 2942 |
|
|
2020
Q4 | $621K | Sell |
13,392
-1,220
| -8% | -$56.6K | ﹤0.01% | 2541 |
|
|
2020
Q3 | $481K | Buy |
14,612
+1,587
| +12% | +$52.2K | ﹤0.01% | 2485 |
|
|
2020
Q2 | $358K | Buy |
13,025
+1,817
| +16% | +$49.9K | ﹤0.01% | 2597 |
|
|
2020
Q1 | $336K | Buy |
+11,208
| New | +$336K | ﹤0.01% | 2498 |
|